References
- Brunstetter F. H., Claman H. N. Impairment of delayed hypersensitivity in uremic patients by antilymphocyte serum. Transplantation 1968; 6: 485–487
- Currey H. L. F., Ziff M. Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin. J. exp. Med. 1968; 127: 185–203
- Domingo E. O., Warren K. S. The inhibition of granuloma formation around Schistosoma mansoni eggs. III. Heterologous antilymphocyte serum. Amer. J. Path. 1968; 52: 613–631
- Hoy Wendy E., Nelson D. S. Delayed-type hypersensitivity in mice after skin and tumour allografts and tumour iso-grafts. Mature (Land.). 1969; 222: 1001–1003
- Inderbitzen T. The relationship of lymphocytes, delayed cutaneous allergic reactions and histamine. Int. Arch. Allergy 1956; 8: 150–159
- James K. Anti-lymphocytic antibody—a review. Clin. exp. Immunol. 1967; 2: 615–631
- Jooste Somarie V., Lance E. M., Levey R. H. Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology 1968; 15: 697–705
- Lance E. Erasure of immunological memory with anti-lymphocyte serum. Nature (Lond.). 1968; 217: 557–558
- Leibowitz S., Lessof M. H., Kennedy L. A. The effect of anti-lymphocyte serum on experimental allergic encephalomyelitis in the guinea-pig. Clin. exp. Immunol. 1968; 3: 753–760
- Levey R. H., Medawar P. B. Nature and mode of action of antilymphocytic anti-serum. Proc. nat. Acad. Sci. (Wash.). 1966; 56: 1130–1137
- Martin W. J. Experimental studies relating to the production and clinical testing of anti-human lymphocyte serum. Med. J. Aust. 1969; 2: 450–455
- Martin W. J., Miller J. F. A. P. Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J. exp. Med. 1968; 128: 855–874
- Martin W. J., Miller J. F. A. P. Assay for the immunosuppressive capacity of antilymphocyte serum based on its action on thymus-derived cells. Int. Arch. Allergy 1969; 35: 163–178
- Mildenhall P., Nelson D. S. Serological responses of mice during active enhancement of tumour allografts. Brit. J. exp. Path. 1968; 49: 170–178
- Nelson D. S., Mildenhall P. Studies on cytophilic antibodies. I. The production by mice of macrophage cytophilic antibodies to sheep erythrocytes: relationship to the production of other antibodies and the development of delayed-type hypersensitivity. Aust. J. exp. Biol. med. Sci. 1967; 45: 113–130
- Pernis B., Bairati A., Milanesi S. Cellular and humoral reactions to Freund's adjuvant in guinea-pigs. Path. et Microbiol. 1966; 29: 837–853
- Potworowski E. F., Nairn R. C. Origin and fate of a thymocyte-specific antigen. Immunology 1967; 13: 597–602
- Roitt I. M., Greaves M. F., Torrigiani G. The cellular basis of immunological responses. A synthesis of some current views. Lancet 1969; 2: 367–371
- Russell P. S. Antilymphocyte serum as an immunosuppressive agent. Ann. int. Med. 1968; 68: 483–486
- Sheil A. G. R., Rogers J. H. Antilymphocyte serum: a review with report of the current clinical situation in Australia. Med. J. Aust. 1969; 1: 1370–1375
- Turk J. L., Polak L. Action of antilymphocytic sera on reactions caused by immune-complex formation. Lancet 1969; 1: 130–131
- Turk J. L., Willoughby D. A. Central and peripheral effects of anti-lymphocyte sera. Lancet 1967; 1: 249–251
- Waksman B. H., Arbouys Simone, Arnason B. G. The use of specific 'lymphocyte' antisera to inhibit hypersensitive reactions of the 'delayed' type. J. exp. Med. 1961; 114: 997–1022
- Antilymphocyte Serum. (Ciba Foundation Study Group No. 29), G. E. W. Wolstenholme, Maeve O'Connor. J. & A. Churchill Ltd., London 1967